Zydus Cadila gets USFDA nod for injection

February 25, 2013 16:44

Pharmaceuticals firm Zydus Cadila today said it has received final approval from US health regulator to market generic Ranitidine Hcl (hydroclhoride) injection used in treating peptic ulcers.

The approval from the US Food and Drug Administration (USFDA) is for Ranitidine Hcl injection of strength 25mg/ml, the company said in a filing to the BSE.

Citing IMS data, the company said the estimated sales of Ranitidine Hcl was USD 5.4 million in 2012.

« Back to LIVE

TOP STORIES

Let The Election Games Begin!

Polling and police officers travel in a boat with election materials to reach to a remote polling station ahead of the first phase of India's general election in the Majuli district, Assam, April 18, 2024.

MI Vs PBKS: Who Bowled Best? Vote!

Bumrah, Coetzee and Patel all took three wickets each.

Kerala woman cadet onboard ship seized by Iran returns home

At the airport, Joseph was received by the regional passport officer.

SC sets aside T'gana HC order declaring 106 acre of forest land as private

The humans have "selective amnesia" about the significance of forests, the Supreme Court said on Thursday while advocating the need for a change in approach towards natural resources from anthropocentric to ecocentric.

'Sun will rise tomorrow!' Curran vows PBKS' turnaround

Stand-in captain Sam Curran lauded the efforts of Ashutosh Sharma and Shashank Singh, who displayed remarkable composure in a high-pressure chase.